Hello, everyone, and nice to see you again. We hope your extended weekend - on this side of the pond, that is - was pleasant. Now, of course, the routine resumes with all those meetings and deadlines. So please join us for a cup of stimulation as we dust the snow off the Pharmalot corporate campus, ready the short people for the school house and prowl around for interesting items. Hope your day goes well and do stay in touch...
FDA Staff Questions Lilly Alzheimer's Drug (Reuters)
Teva Will Lay Off 200 California Workers (Orange County Register)
Pfizer Sued Over Dilantin Side Effects (Madison-St. Clair Record)
Ariad Stock Pops After Sarcoma Drug Meets Study Goal (Bloomberg News)
Servier Chief Called To Mediator Court Hearing (The Telegraph)
EU Will Ask Sanofi To Write Docs About Multaq Problems (Reuters)
Roche Names New Chief Financial Officer (Bloomberg News)
Denver Hospitals Review Relationships With Pharma (Denver Post)
Former EMA Director Joins Industry Consultant (Pharma Times)
UK Legal Aid Cuts Give Pharma A Boost In Court (BBC)
INC Buys Avos Life Sciences (Outsourcing Pharma)
Some Antibiotics And Blood Pressure Meds Don't Mix (HealthDay)